New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective
Glioblastoma multiforme (GBM) is the most common tumor of the CNS, and the deadliest form of brain cancer. The rapid progression, the anatomic location in the brain and a deficient knowledge of the pathophysiology, often limit the effectiveness of therapeutic interventions. Current pillars of GBM th...
Main Authors: | Simona Sestito, Massimiliano Runfola, Marco Tonelli, Grazia Chiellini, Simona Rapposelli |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.00874/full |
Similar Items
-
Hydrogen Sulfide: A Worthwhile Tool in the Design of New Multitarget Drugs
by: Simona Sestito, et al.
Published: (2017-09-01) -
Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases
by: Andrea Bacci, et al.
Published: (2021-02-01) -
Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders
by: Federica Saponaro, et al.
Published: (2020-07-01) -
A Definition of “Multitargeticity”: Identifying Potential Multitarget and Selective Ligands Through a Vector Analysis
by: Juan Francisco Sánchez-Tejeda, et al.
Published: (2020-03-01) -
Novel Multitarget Therapies for Lung Cancer and Respiratory Disease
by: Masako Yumura, et al.
Published: (2020-09-01)